ProShares · 2010-04-06 成立 · 规模、费率、NAV、资金流、完整持仓和风险收益使用各自可追溯公开源。
| 日期 | 估算净流 | 申购 / 销售 | 赎回 | 净资产 | 口径 |
|---|---|---|---|---|---|
| 2026-07-31 | -$2.9M | — | — | $82.9M | 每日估算 |
| 2026-07-30 | +$3.0M | — | — | $84.4M | 每日估算 |
| 2026-07-29 | -$956,366 | — | — | $82.8M | 每日估算 |
| 2026-07-28 | -$2.1M | — | — | $82.2M | 每日估算 |
| 2026-07-27 | +$1.4M | — | — | $83.7M |
| 持仓 | 资产类别 | 数量 | 市值 | 权重 |
|---|---|---|---|---|
Gilead Sciences, Inc. Gilead Sciences, Inc. | EC | 39,904 | $5.9M | 6.48% |
Total Return Swap Total Return Swap | DE | 4,291 | $5.8M | 6.34% |
Vertex Pharmaceuticals, Inc. Vertex Pharmaceuticals, Inc. | EC | 11,581 | $5.8M | 6.27% |
Amgen, Inc. Amgen, Inc. |
行情与风险截至 2026-07-30；NAV 的发布时间可能和交易所收盘错位。完整持仓是延迟监管披露，不代表当前盘中组合。
已使用：nasdaq_etf_screener、nasdaq_etf_summary、yahoo_chart、yahoo_quote_summary、sec_nport。缺口标记：nav_timestamp_unverified。
| 每日估算 |
| 2026-07-26 | +$974,361 | — | — | $83.2M | 每日估算 |
| 2026-07-25 | +$974,361 | — | — | $83.2M | 每日估算 |
| 2026-02-28 | -$888,602 | $0 | $888,602 | $91.7M | SEC 月度 |
| 2026-01-31 | -$58,840 | $1.6M | $1.7M | — | SEC 月度 |
| 2025-12-31 | -$6,013 | $788,472 | $794,486 | — | SEC 月度 |
| EC |
| 14,536 |
| $5.6M |
| 6.15% |
Regeneron Pharmaceuticals, Inc. Regeneron Pharmaceuticals, Inc. | EC | 4,769 | $3.7M | 4.06% |
Total Return Swap Total Return Swap | DE | 2,484 | $3.3M | 3.61% |
Total Return Swap Total Return Swap | DE | 2,639 | $2.7M | 2.89% |
Total Return Swap Total Return Swap | DE | 6,179 | $2.6M | 2.85% |
Total Return Swap Total Return Swap | DE | 3,646 | $2.4M | 2.63% |
Alnylam Pharmaceuticals, Inc. Alnylam Pharmaceuticals, Inc. | EC | 6,101 | $2.0M | 2.21% |
INVESCO GOVERNMENT & AGENCY PORTFOLIO OPEN-END FUND USD INVESCO GOVERNMENT & AGENCY PORTFOLIO OPEN-END FUND USD | STIV | 1,662,869 | $1.7M | 1.81% |
Repurchase Agreement Repurchase Agreement | RA | 1,567,851 | $1.6M | 1.71% |
Insmed, Inc. Insmed, Inc. | EC | 9,848 | $1.5M | 1.60% |
Biogen, Inc. Biogen, Inc. | EC | 6,774 | $1.3M | 1.42% |
Argenx SE Argenx SE | EC | 1,344 | $1.0M | 1.12% |
United Therapeutics Corp. United Therapeutics Corp. | EC | 1,988 | $1.0M | 1.09% |
Moderna, Inc. Moderna, Inc. | EC | 18,039 | $966,349 | 1.05% |
Illumina, Inc. Illumina, Inc. | EC | 7,055 | $948,615 | 1.03% |
Roivant Sciences Ltd. Roivant Sciences Ltd. | EC | 32,114 | $929,379 | 1.01% |
Incyte Corp. Incyte Corp. | EC | 9,065 | $918,013 | 1.00% |
Royalty Pharma plc, Class A Royalty Pharma plc, Class A | EC | 19,729 | $911,677 | 0.99% |
Revolution Medicines, Inc. Revolution Medicines, Inc. | EC | 8,927 | $910,733 | 0.99% |
Viatris, Inc. Viatris, Inc. | EC | 53,183 | $794,022 | 0.87% |
Repurchase Agreement Repurchase Agreement | RA | 776,976 | $776,976 | 0.85% |
Repurchase Agreement Repurchase Agreement | RA | 776,976 | $776,976 | 0.85% |
Ascendis Pharma A/S Ascendis Pharma A/S | EC | 2,835 | $661,973 | 0.72% |
Neurocrine Biosciences, Inc. Neurocrine Biosciences, Inc. | EC | 4,604 | $608,879 | 0.66% |
Ionis Pharmaceuticals, Inc. Ionis Pharmaceuticals, Inc. | EC | 7,479 | $606,921 | 0.66% |
Sanofi SA Sanofi SA | EC | 12,219 | $594,577 | 0.65% |
Bridgebio Pharma, Inc. Bridgebio Pharma, Inc. | EC | 8,897 | $591,473 | 0.64% |
Medpace Holdings, Inc. Medpace Holdings, Inc. | EC | 1,301 | $587,740 | 0.64% |
Summit Therapeutics, Inc. Summit Therapeutics, Inc. | EC | 34,375 | $570,281 | 0.62% |
Guardant Health, Inc. Guardant Health, Inc. | EC | 5,974 | $560,959 | 0.61% |
BioMarin Pharmaceutical, Inc. BioMarin Pharmaceutical, Inc. | EC | 8,871 | $547,607 | 0.60% |
Exelixis, Inc. Exelixis, Inc. | EC | 12,381 | $545,507 | 0.59% |
Jazz Pharmaceuticals plc Jazz Pharmaceuticals plc | EC | 2,806 | $533,196 | 0.58% |
BioNTech SE BioNTech SE | EC | 4,669 | $514,664 | 0.56% |
Repurchase Agreement Repurchase Agreement | RA | 466,185 | $466,185 | 0.51% |
Repurchase Agreement Repurchase Agreement | RA | 466,185 | $466,185 | 0.51% |
BeOne Medicines Ltd. BeOne Medicines Ltd. | EC | 1,454 | $460,903 | 0.50% |
Madrigal Pharmaceuticals, Inc. Madrigal Pharmaceuticals, Inc. | EC | 1,048 | $452,736 | 0.49% |
ImmunityBio, Inc. ImmunityBio, Inc. | EC | 45,481 | $444,804 | 0.49% |
Tempus AI, Inc., Class A Tempus AI, Inc., Class A | EC | 7,982 | $425,042 | 0.46% |
Arrowhead Pharmaceuticals, Inc. Arrowhead Pharmaceuticals, Inc. | EC | 6,271 | $396,766 | 0.43% |
Praxis Precision Medicines, Inc. Praxis Precision Medicines, Inc. | EC | 1,155 | $388,946 | 0.42% |
Repurchase Agreement Repurchase Agreement | RA | 388,488 | $388,488 | 0.42% |
Axsome Therapeutics, Inc. Axsome Therapeutics, Inc. | EC | 2,327 | $381,372 | 0.42% |
Halozyme Therapeutics, Inc. Halozyme Therapeutics, Inc. | EC | 5,430 | $377,548 | 0.41% |
Vaxcyte, Inc. Vaxcyte, Inc. | EC | 6,044 | $373,157 | 0.41% |
Krystal Biotech, Inc. Krystal Biotech, Inc. | EC | 1,339 | $369,082 | 0.40% |
Cytokinetics, Inc. Cytokinetics, Inc. | EC | 5,646 | $351,294 | 0.38% |
Nuvalent, Inc., Class A Nuvalent, Inc., Class A | EC | 3,335 | $340,003 | 0.37% |
Abivax SA Abivax SA | EC | 2,726 | $330,609 | 0.36% |
Repurchase Agreement Repurchase Agreement | RA | 310,790 | $310,790 | 0.34% |
Repurchase Agreement Repurchase Agreement | RA | 310,790 | $310,790 | 0.34% |
Arcellx, Inc. Arcellx, Inc. | EC | 2,670 | $303,819 | 0.33% |
Kymera Therapeutics, Inc. Kymera Therapeutics, Inc. | EC | 3,322 | $303,465 | 0.33% |
Rhythm Pharmaceuticals, Inc. Rhythm Pharmaceuticals, Inc. | EC | 3,082 | $285,794 | 0.31% |
Cogent Biosciences, Inc. Cogent Biosciences, Inc. | EC | 7,088 | $275,369 | 0.30% |
Protagonist Therapeutics, Inc. Protagonist Therapeutics, Inc. | EC | 2,887 | $265,835 | 0.29% |
CRISPR Therapeutics AG CRISPR Therapeutics AG | EC | 4,400 | $264,616 | 0.29% |
Caris Life Sciences, Inc. Caris Life Sciences, Inc. | EC | 13,029 | $262,404 | 0.29% |
PTC Therapeutics, Inc. PTC Therapeutics, Inc. | EC | 3,707 | $252,780 | 0.28% |
Alkermes plc Alkermes plc | EC | 7,624 | $229,482 | 0.25% |
Immunovant, Inc. Immunovant, Inc. | EC | 8,094 | $224,447 | 0.24% |
CG oncology, Inc. CG oncology, Inc. | EC | 3,725 | $219,030 | 0.24% |
Mirum Pharmaceuticals, Inc. Mirum Pharmaceuticals, Inc. | EC | 2,373 | $219,004 | 0.24% |
Scholar Rock Holding Corp. Scholar Rock Holding Corp. | EC | 4,710 | $208,512 | 0.23% |
Amicus Therapeutics, Inc. Amicus Therapeutics, Inc. | EC | 14,247 | $204,729 | 0.22% |
Amneal Pharmaceuticals, Inc. Amneal Pharmaceuticals, Inc. | EC | 14,516 | $200,466 | 0.22% |
Structure Therapeutics, Inc. Structure Therapeutics, Inc. | EC | 3,086 | $194,356 | 0.21% |
ACADIA Pharmaceuticals, Inc. ACADIA Pharmaceuticals, Inc. | EC | 7,812 | $191,863 | 0.21% |
Indivior Pharmaceuticals, Inc. Indivior Pharmaceuticals, Inc. | EC | 5,763 | $188,565 | 0.21% |
Newamsterdam Pharma Co. NV Newamsterdam Pharma Co. NV | EC | 5,236 | $185,669 | 0.20% |
Ligand Pharmaceuticals, Inc. Ligand Pharmaceuticals, Inc. | EC | 909 | $180,264 | 0.20% |
Crinetics Pharmaceuticals, Inc. Crinetics Pharmaceuticals, Inc. | EC | 4,382 | $180,100 | 0.20% |
Erasca, Inc. Erasca, Inc. | EC | 13,101 | $178,960 | 0.20% |
Apogee Therapeutics, Inc. Apogee Therapeutics, Inc. | EC | 2,532 | $177,240 | 0.19% |
Terns Pharmaceuticals, Inc. Terns Pharmaceuticals, Inc. | EC | 4,160 | $175,219 | 0.19% |
ADMA Biologics, Inc. ADMA Biologics, Inc. | EC | 10,990 | $171,114 | 0.19% |
Repurchase Agreement Repurchase Agreement | RA | 155,395 | $155,395 | 0.17% |
Xenon Pharmaceuticals, Inc. Xenon Pharmaceuticals, Inc. | EC | 3,568 | $154,245 | 0.17% |
Spyre Therapeutics, Inc. Spyre Therapeutics, Inc. | EC | 3,583 | $154,105 | 0.17% |
Arcutis Biotherapeutics, Inc. Arcutis Biotherapeutics, Inc. | EC | 5,656 | $152,542 | 0.17% |
Edgewise Therapeutics, Inc. Edgewise Therapeutics, Inc. | EC | 4,889 | $148,821 | 0.16% |
Tarsus Pharmaceuticals, Inc. Tarsus Pharmaceuticals, Inc. | EC | 1,961 | $148,095 | 0.16% |
Supernus Pharmaceuticals, Inc. Supernus Pharmaceuticals, Inc. | EC | 2,648 | $144,925 | 0.16% |
Denali Therapeutics, Inc. Denali Therapeutics, Inc. | EC | 6,772 | $143,431 | 0.16% |
Veracyte, Inc. Veracyte, Inc. | EC | 3,650 | $133,554 | 0.15% |
Beam Therapeutics, Inc. Beam Therapeutics, Inc. | EC | 4,685 | $133,335 | 0.15% |
Alumis, Inc. Alumis, Inc. | EC | 4,489 | $133,278 | 0.15% |
Twist Bioscience Corp. Twist Bioscience Corp. | EC | 2,823 | $132,455 | 0.14% |
Ideaya Biosciences, Inc. Ideaya Biosciences, Inc. | EC | 4,048 | $130,346 | 0.14% |
10X Genomics, Inc., Class A 10X Genomics, Inc., Class A | EC | 5,379 | $123,986 | 0.14% |
Travere Therapeutics, Inc. Travere Therapeutics, Inc. | EC | 4,131 | $123,062 | 0.13% |
Apellis Pharmaceuticals, Inc. Apellis Pharmaceuticals, Inc. | EC | 5,839 | $122,385 | 0.13% |
Vera Therapeutics, Inc., Class A Vera Therapeutics, Inc., Class A | EC | 2,950 | $120,331 | 0.13% |
Centessa Pharmaceuticals plc Centessa Pharmaceuticals plc | EC | 4,455 | $119,661 | 0.13% |
Disc Medicine, Inc. Disc Medicine, Inc. | EC | 1,744 | $116,185 | 0.13% |
Adaptive Biotechnologies Corp. Adaptive Biotechnologies Corp. | EC | 7,049 | $112,925 | 0.12% |
WaVe Life Sciences Ltd. WaVe Life Sciences Ltd. | EC | 7,723 | $107,581 | 0.12% |
Mineralys Therapeutics, Inc. Mineralys Therapeutics, Inc. | EC | 3,654 | $106,916 | 0.12% |
Ultragenyx Pharmaceutical, Inc. Ultragenyx Pharmaceutical, Inc. | EC | 4,455 | $104,202 | 0.11% |
Dyne Therapeutics, Inc. Dyne Therapeutics, Inc. | EC | 6,595 | $103,014 | 0.11% |
Maze Therapeutics, Inc. Maze Therapeutics, Inc. | EC | 2,222 | $101,301 | 0.11% |
Stoke Therapeutics, Inc. Stoke Therapeutics, Inc. | EC | 2,638 | $96,050 | 0.10% |
GRAIL, Inc. GRAIL, Inc. | EC | 1,800 | $95,814 | 0.10% |
Kiniksa Pharmaceuticals International plc, Class A Kiniksa Pharmaceuticals International plc, Class A | EC | 2,086 | $92,806 | 0.10% |
Harrow, Inc. Harrow, Inc. | EC | 1,710 | $92,648 | 0.10% |
Ocular Therapeutix, Inc. Ocular Therapeutix, Inc. | EC | 9,837 | $87,943 | 0.10% |
Olema Pharmaceuticals, Inc. Olema Pharmaceuticals, Inc. | EC | 3,632 | $87,894 | 0.10% |
Syndax Pharmaceuticals, Inc. Syndax Pharmaceuticals, Inc. | EC | 4,014 | $87,144 | 0.10% |
Recursion Pharmaceuticals, Inc., Class A Recursion Pharmaceuticals, Inc., Class A | EC | 23,743 | $87,137 | 0.10% |
Aurinia Pharmaceuticals, Inc. Aurinia Pharmaceuticals, Inc. | EC | 6,088 | $86,267 | 0.09% |
BioCryst Pharmaceuticals, Inc. BioCryst Pharmaceuticals, Inc. | EC | 9,722 | $85,068 | 0.09% |
Pharvaris NV Pharvaris NV | EC | 2,958 | $83,978 | 0.09% |
Vericel Corp. Vericel Corp. | EC | 2,335 | $83,313 | 0.09% |
Relay Therapeutics, Inc. Relay Therapeutics, Inc. | EC | 8,003 | $82,111 | 0.09% |
Tyra Biosciences, Inc. Tyra Biosciences, Inc. | EC | 2,464 | $82,076 | 0.09% |
Enliven Therapeutics, Inc. Enliven Therapeutics, Inc. | EC | 2,741 | $81,380 | 0.09% |
Agios Pharmaceuticals, Inc. Agios Pharmaceuticals, Inc. | EC | 2,692 | $81,379 | 0.09% |
Sarepta Therapeutics, Inc. Sarepta Therapeutics, Inc. | EC | 4,838 | $81,085 | 0.09% |
Zymeworks, Inc. Zymeworks, Inc. | EC | 3,456 | $80,490 | 0.09% |
Genmab A/S Genmab A/S | EC | 2,699 | $79,459 | 0.09% |
Definium Therapeutics, Inc. Definium Therapeutics, Inc. | EC | 4,548 | $79,363 | 0.09% |
Innoviva, Inc. Innoviva, Inc. | EC | 3,453 | $79,281 | 0.09% |
Oruka Therapeutics, Inc. Oruka Therapeutics, Inc. | EC | 2,236 | $76,941 | 0.08% |
Amylyx Pharmaceuticals, Inc. Amylyx Pharmaceuticals, Inc. | EC | 5,071 | $76,927 | 0.08% |
ANI Pharmaceuticals, Inc. ANI Pharmaceuticals, Inc. | EC | 1,037 | $76,634 | 0.08% |
Novavax, Inc. Novavax, Inc. | EC | 7,504 | $76,091 | 0.08% |
Harmony Biosciences Holdings, Inc. Harmony Biosciences Holdings, Inc. | EC | 2,660 | $75,916 | 0.08% |
Sionna Therapeutics, Inc. Sionna Therapeutics, Inc. | EC | 2,061 | $75,309 | 0.08% |
Nurix Therapeutics, Inc. Nurix Therapeutics, Inc. | EC | 4,680 | $74,740 | 0.08% |
RAPT Therapeutics, Inc. RAPT Therapeutics, Inc. | EC | 1,279 | $74,156 | 0.08% |
Legend Biotech Corp. Legend Biotech Corp. | EC | 3,888 | $73,872 | 0.08% |
Intellia Therapeutics, Inc. Intellia Therapeutics, Inc. | EC | 5,348 | $73,695 | 0.08% |
Ardelyx, Inc. Ardelyx, Inc. | EC | 11,220 | $73,491 | 0.08% |
Iovance Biotherapeutics, Inc. Iovance Biotherapeutics, Inc. | EC | 18,330 | $70,754 | 0.08% |
Novocure Ltd. Novocure Ltd. | EC | 5,171 | $70,688 | 0.08% |
Trevi Therapeutics, Inc. Trevi Therapeutics, Inc. | EC | 5,921 | $70,578 | 0.08% |
AnaptysBio, Inc. AnaptysBio, Inc. | EC | 1,278 | $70,354 | 0.08% |
Tango Therapeutics, Inc. Tango Therapeutics, Inc. | EC | 6,219 | $69,280 | 0.08% |
MBX Biosciences, Inc. MBX Biosciences, Inc. | EC | 2,073 | $67,476 | 0.07% |
EyePoint, Inc. EyePoint, Inc. | EC | 3,822 | $67,114 | 0.07% |
Kodiak Sciences, Inc. Kodiak Sciences, Inc. | EC | 2,450 | $65,660 | 0.07% |
Zenas Biopharma, Inc. Zenas Biopharma, Inc. | EC | 2,478 | $65,295 | 0.07% |
Immunocore Holdings plc Immunocore Holdings plc | EC | 2,015 | $65,085 | 0.07% |
Rapport Therapeutics, Inc. Rapport Therapeutics, Inc. | EC | 2,201 | $63,895 | 0.07% |
Corvus Pharmaceuticals, Inc. Corvus Pharmaceuticals, Inc. | EC | 3,449 | $62,979 | 0.07% |
Precigen, Inc. Precigen, Inc. | EC | 16,338 | $61,921 | 0.07% |
AtaiBeckley, Inc. AtaiBeckley, Inc. | EC | 16,770 | $60,875 | 0.07% |
Collegium Pharmaceutical, Inc. Collegium Pharmaceutical, Inc. | EC | 1,460 | $60,838 | 0.07% |
ORIC Pharmaceuticals, Inc. ORIC Pharmaceuticals, Inc. | EC | 4,497 | $60,485 | 0.07% |
Septerna, Inc. Septerna, Inc. | EC | 2,067 | $59,984 | 0.07% |
Vir Biotechnology, Inc. Vir Biotechnology, Inc. | EC | 6,424 | $58,394 | 0.06% |
Alvotech SA Alvotech SA | EC | 14,454 | $57,671 | 0.06% |
Taysha Gene Therapies, Inc. Taysha Gene Therapies, Inc. | EC | 12,648 | $57,295 | 0.06% |
Savara, Inc. Savara, Inc. | EC | 9,395 | $56,558 | 0.06% |
Monte Rosa Therapeutics, Inc. Monte Rosa Therapeutics, Inc. | EC | 3,007 | $53,374 | 0.06% |
Sana Biotechnology, Inc. Sana Biotechnology, Inc. | EC | 12,300 | $51,783 | 0.06% |
Phibro Animal Health Corp., Class A Phibro Animal Health Corp., Class A | EC | 946 | $51,642 | 0.06% |
Grifols SA Grifols SA | EC | 5,633 | $51,260 | 0.06% |
Day One Biopharmaceuticals, Inc. Day One Biopharmaceuticals, Inc. | EC | 4,741 | $50,255 | 0.05% |
AbCellera Biologics, Inc. AbCellera Biologics, Inc. | EC | 13,822 | $49,897 | 0.05% |
Inhibrx Biosciences, Inc. Inhibrx Biosciences, Inc. | EC | 672 | $49,815 | 0.05% |
Geron Corp. Geron Corp. | EC | 29,476 | $49,520 | 0.05% |
UroGen Pharma Ltd. UroGen Pharma Ltd. | EC | 2,162 | $46,915 | 0.05% |
Xeris Biopharma Holdings, Inc. Xeris Biopharma Holdings, Inc. | EC | 7,662 | $46,891 | 0.05% |
MannKind Corp. MannKind Corp. | EC | 14,180 | $46,510 | 0.05% |
Ventyx Biosciences, Inc. Ventyx Biosciences, Inc. | EC | 3,295 | $46,031 | 0.05% |
Fortrea Holdings, Inc. Fortrea Holdings, Inc. | EC | 4,266 | $45,732 | 0.05% |
uniQure NV uniQure NV | EC | 2,877 | $44,968 | 0.05% |
ArriVent Biopharma, Inc. ArriVent Biopharma, Inc. | EC | 1,906 | $43,781 | 0.05% |
Pacira BioSciences, Inc. Pacira BioSciences, Inc. | EC | 1,986 | $43,513 | 0.05% |
Amphastar Pharmaceuticals, Inc. Amphastar Pharmaceuticals, Inc. | EC | 2,122 | $42,928 | 0.05% |
Theravance Biopharma, Inc. Theravance Biopharma, Inc. | EC | 2,340 | $42,705 | 0.05% |
GH Research plc GH Research plc | EC | 2,864 | $42,530 | 0.05% |
Bicara Therapeutics, Inc. Bicara Therapeutics, Inc. | EC | 2,530 | $42,453 | 0.05% |
ARS Pharmaceuticals, Inc. ARS Pharmaceuticals, Inc. | EC | 4,564 | $42,354 | 0.05% |
Cullinan Therapeutics, Inc. Cullinan Therapeutics, Inc. | EC | 2,728 | $42,284 | 0.05% |
Xencor, Inc. Xencor, Inc. | EC | 3,298 | $42,115 | 0.05% |
CytomX Therapeutics, Inc. CytomX Therapeutics, Inc. | EC | 7,823 | $42,010 | 0.05% |
Arbutus Biopharma Corp. Arbutus Biopharma Corp. | EC | 8,881 | $41,385 | 0.05% |
Phathom Pharmaceuticals, Inc. Phathom Pharmaceuticals, Inc. | EC | 3,285 | $41,260 | 0.04% |
Castle Biosciences, Inc. Castle Biosciences, Inc. | EC | 1,348 | $39,860 | 0.04% |
Omeros Corp. Omeros Corp. | EC | 3,274 | $39,452 | 0.04% |
Arvinas, Inc. Arvinas, Inc. | EC | 2,965 | $39,346 | 0.04% |
Prime Medicine, Inc. Prime Medicine, Inc. | EC | 8,335 | $38,508 | 0.04% |
KalVista Pharmaceuticals, Inc. KalVista Pharmaceuticals, Inc. | EC | 2,334 | $37,998 | 0.04% |
Janux Therapeutics, Inc. Janux Therapeutics, Inc. | EC | 2,777 | $37,795 | 0.04% |
Annexon, Inc. Annexon, Inc. | EC | 6,683 | $37,425 | 0.04% |
Personalis, Inc. Personalis, Inc. | EC | 4,101 | $37,155 | 0.04% |
Esperion Therapeutics, Inc. Esperion Therapeutics, Inc. | EC | 11,038 | $36,977 | 0.04% |
BioAge Labs, Inc. BioAge Labs, Inc. | EC | 1,656 | $36,879 | 0.04% |
Mesoblast Ltd. Mesoblast Ltd. | EC | 2,264 | $35,884 | 0.04% |
Kura Oncology, Inc. Kura Oncology, Inc. | EC | 4,018 | $35,077 | 0.04% |
Zai Lab Ltd. Zai Lab Ltd. | EC | 1,808 | $34,750 | 0.04% |
Compass Pathways plc Compass Pathways plc | EC | 4,351 | $30,022 | 0.03% |
Rigel Pharmaceuticals, Inc. Rigel Pharmaceuticals, Inc. | EC | 838 | $29,112 | 0.03% |
Allogene Therapeutics, Inc. Allogene Therapeutics, Inc. | EC | 10,377 | $28,848 | 0.03% |
MeiraGTx Holdings plc MeiraGTx Holdings plc | EC | 3,717 | $28,101 | 0.03% |
Replimune Group, Inc. Replimune Group, Inc. | EC | 3,622 | $27,708 | 0.03% |
Design Therapeutics, Inc. Design Therapeutics, Inc. | EC | 2,630 | $27,457 | 0.03% |
Neumora Therapeutics, Inc. Neumora Therapeutics, Inc. | EC | 7,715 | $26,925 | 0.03% |
CorMedix, Inc. CorMedix, Inc. | EC | 3,638 | $25,939 | 0.03% |
Ironwood Pharmaceuticals, Inc., Class A Ironwood Pharmaceuticals, Inc., Class A | EC | 7,512 | $25,691 | 0.03% |
4D Molecular Therapeutics, Inc. 4D Molecular Therapeutics, Inc. | EC | 2,638 | $25,483 | 0.03% |
Rocket Pharmaceuticals, Inc. Rocket Pharmaceuticals, Inc. | EC | 4,990 | $25,000 | 0.03% |
Vanda Pharmaceuticals, Inc. Vanda Pharmaceuticals, Inc. | EC | 2,729 | $24,315 | 0.03% |
Lexeo Therapeutics, Inc. Lexeo Therapeutics, Inc. | EC | 3,370 | $24,197 | 0.03% |
Maravai LifeSciences Holdings, Inc., Class A Maravai LifeSciences Holdings, Inc., Class A | EC | 6,696 | $23,838 | 0.03% |
Lyell Immunopharma, Inc. Lyell Immunopharma, Inc. | EC | 979 | $23,496 | 0.03% |
Pacific Biosciences of California, Inc. Pacific Biosciences of California, Inc. | EC | 13,941 | $23,421 | 0.03% |
Zevra Therapeutics, Inc. Zevra Therapeutics, Inc. | EC | 2,600 | $23,218 | 0.03% |
Kamada Ltd. Kamada Ltd. | EC | 2,664 | $23,177 | 0.03% |
Aquestive Therapeutics, Inc. Aquestive Therapeutics, Inc. | EC | 5,633 | $22,532 | 0.02% |
Galapagos NV Galapagos NV | EC | 668 | $22,485 | 0.02% |
Solid Biosciences, Inc. Solid Biosciences, Inc. | EC | 3,598 | $22,344 | 0.02% |
Invivyd, Inc. Invivyd, Inc. | EC | 12,796 | $21,625 | 0.02% |
Prothena Corp. plc Prothena Corp. plc | EC | 2,485 | $21,545 | 0.02% |
SIGA Technologies, Inc. SIGA Technologies, Inc. | EC | 3,307 | $21,396 | 0.02% |
REGENXBIO, Inc. REGENXBIO, Inc. | EC | 2,337 | $21,126 | 0.02% |
Entrada Therapeutics, Inc. Entrada Therapeutics, Inc. | EC | 1,765 | $21,056 | 0.02% |
Eton Pharmaceuticals, Inc. Eton Pharmaceuticals, Inc. | EC | 1,239 | $21,051 | 0.02% |
Larimar Therapeutics, Inc. Larimar Therapeutics, Inc. | EC | 3,953 | $20,990 | 0.02% |
Fulcrum Therapeutics, Inc. Fulcrum Therapeutics, Inc. | EC | 2,499 | $20,942 | 0.02% |
Altimmune, Inc. Altimmune, Inc. | EC | 4,819 | $20,770 | 0.02% |
Tectonic Therapeutic, Inc. Tectonic Therapeutic, Inc. | EC | 864 | $20,261 | 0.02% |
Keros Therapeutics, Inc. Keros Therapeutics, Inc. | EC | 1,406 | $19,951 | 0.02% |
PepGen, Inc. PepGen, Inc. | EC | 3,175 | $19,749 | 0.02% |
LENZ Therapeutics, Inc. LENZ Therapeutics, Inc. | EC | 1,445 | $19,493 | 0.02% |
Upstream Bio, Inc. Upstream Bio, Inc. | EC | 2,495 | $19,162 | 0.02% |
Enanta Pharmaceuticals, Inc. Enanta Pharmaceuticals, Inc. | EC | 1,332 | $19,048 | 0.02% |
Absci Corp. Absci Corp. | EC | 6,944 | $19,027 | 0.02% |
Anavex Life Sciences Corp. Anavex Life Sciences Corp. | EC | 4,125 | $18,274 | 0.02% |
Aura Biosciences, Inc. Aura Biosciences, Inc. | EC | 2,932 | $17,269 | 0.02% |
Atea Pharmaceuticals, Inc. Atea Pharmaceuticals, Inc. | EC | 3,607 | $16,881 | 0.02% |
Neurogene, Inc. Neurogene, Inc. | EC | 715 | $16,795 | 0.02% |
Kyverna Therapeutics, Inc. Kyverna Therapeutics, Inc. | EC | 2,023 | $16,609 | 0.02% |
Contineum Therapeutics, Inc., Class A Contineum Therapeutics, Inc., Class A | EC | 1,067 | $16,368 | 0.02% |
Autolus Therapeutics plc Autolus Therapeutics plc | EC | 9,262 | $15,838 | 0.02% |
NovaBridge Biosciences NovaBridge Biosciences | EC | 4,801 | $15,747 | 0.02% |
Immuneering Corp., Class A Immuneering Corp., Class A | EC | 2,981 | $14,875 | 0.02% |
Foghorn Therapeutics, Inc. Foghorn Therapeutics, Inc. | EC | 2,611 | $14,830 | 0.02% |
Cabaletta Bio, Inc. Cabaletta Bio, Inc. | EC | 4,445 | $14,757 | 0.02% |
Aclaris Therapeutics, Inc. Aclaris Therapeutics, Inc. | EC | 5,003 | $14,359 | 0.02% |
AC Immune SA AC Immune SA | EC | 4,636 | $13,583 | 0.01% |
Candel Therapeutics, Inc. Candel Therapeutics, Inc. | EC | 2,535 | $13,309 | 0.01% |
Puma Biotechnology, Inc. Puma Biotechnology, Inc. | EC | 2,326 | $13,258 | 0.01% |
Evolus, Inc. Evolus, Inc. | EC | 2,993 | $12,870 | 0.01% |